bisoprolol has been researched along with metoprolol in 173 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (4.62) | 18.7374 |
| 1990's | 19 (10.98) | 18.2507 |
| 2000's | 75 (43.35) | 29.6817 |
| 2010's | 58 (33.53) | 24.3611 |
| 2020's | 13 (7.51) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Baker, JG | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Carrupt, PA; Guillarme, D; Henchoz, Y; Rudaz, S; Veuthey, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Bard, B; Carrupt, PA; Martel, S | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Charlton, SJ; Dickson, CJ; Duca, JS; Fairhurst, RA; Hornak, V; McKay, DJ; Pearlstein, RA; Reilly, J; Sandham, DA; Shaw, D; Sykes, DA; Velez-Vega, C | 1 |
| Chang, Q; Chen, Z; Hu, G; Hu, L; Li, Q; Long, J | 1 |
| Föh, M; Grotemeyer, KH; Reinhardt-Benmalek, B; Scharafinski, HW; Wörz, R | 1 |
| Müller, RK; Tarnow, J | 1 |
| Eichwede, F; Grote, B; Komar, K; Müller, R; Tarnow, J | 1 |
| Brodde, OE; Deighton, NM; Khamssi, M; Motomura, S; Zerkowski, HR | 1 |
| Folgering, HT; Lammers, JW; van Herwaarden, CL | 2 |
| Burkart, F; Pfisterer, M; Steinmann, E | 1 |
| Bühring, KU; Leopold, G; Pabst, J; Simane, Z; Ungethüm, W; Wiemann, H | 1 |
| Bühring, KU; Garbe, A | 1 |
| Bethge, H; Haasis, R | 1 |
| Bacon, RJ; Cragg, DJ; Tattersfield, AE | 1 |
| Lechat, P | 1 |
| Hoshino, T; Inabe, K; Iwatani, Y; Kaburagi, T; Kimura, R; Ohkura, T; Uchida, S; Yamada, S | 1 |
| Demblon, C; Deroubaix, X; Jeanbaptiste, B; Lens, S; Lins, RL; Poelaert, D; Stockis, A | 1 |
| Bel, KJ; Crijns, HJ; de Langen, CD; Haaksma, J; Lie, KI; van de Ven, LL; van den Berg, MP; Witting, W | 1 |
| Boccanelli, A; Camerini, F; Gavazzi, A; Gronda, E; Maggioni, AP; Opasich, C; Rapezzi, C; Scherillo, M; Sinagra, G; Tavazzi, L | 1 |
| Berthelsen, PG; Lippert, FK; Yndgaard, S | 1 |
| Axel, DI; Brehm, BR; Heinle, H; Karsch, KR; Meergans, M; Pfohl, M | 1 |
| Danser, AH; Hense, HW; Holmer, SR; Mayer, B; Riegger, GA; Schunkert, H | 1 |
| Carson, PE | 1 |
| Sasse, A; Schotten, U; vom Dahl, J | 1 |
| Liedholm, H; Linné, AB; Merlo, J | 1 |
| McMurray, JJ | 1 |
| Witkowska, M | 1 |
| Song, J; White, CM | 1 |
| Bristow, MR | 1 |
| Daniel, WG; Garlichs, C | 1 |
| Dunn, AB; Reddy, P | 1 |
| Goldstein, S; Gottlieb, SS | 1 |
| Frantz, RP | 1 |
| Krum, H; Whorlow, SL | 1 |
| Spinar, J; Vítovec, J | 1 |
| Movahed, A | 1 |
| Chavey, WE | 1 |
| Hart, SM | 1 |
| Bertsch, D; Brehm, BR; Klaussner, M; Schüler, S; Schulze-Osthoff, K; Wesselborg, S; Wolf, SC | 1 |
| Hamada, M; Hara, Y; Hiasa, G; Hiwada, K; Ohtsuka, T; Sasaki, O; Shigematsu, Y; Suzuki, M | 1 |
| Gregory, D; Konstam, MA; Udelson, JE | 1 |
| Nissen, E; Wallukat, G | 1 |
| Lee, S; Spencer, A | 1 |
| Coutinho, J | 1 |
| Bölck, B; Brixius, K; Bundkirchen, A; Mehlhorn, U; Schwinger, RH | 1 |
| Gülker, H; Haverkamp, W; Hindricks, G | 1 |
| Czuriga, I; Edes, I | 1 |
| Ghanem, WM; Murin, J; Sleiman, OI | 1 |
| Adler, S; Kraatz, E; Kurz, T; Nötzold, A; Richardt, D; Richardt, G | 1 |
| Bobadilla, RV | 1 |
| Hayano, T; Itagaki, K; Kimura, M; Matsuzaki, M; Ohmura, M; Shimizu, A; Ueyama, T; Yamagata, T; Yoshiga, Y | 1 |
| Rollins, G | 1 |
| Braza, AJ; Lastra, CF; Mariño, EL; Modamio, P | 1 |
| Balli, E; Geraci, E; Gorini, M; Gronda, E; Lucci, D; Maggioni, AP; Opasich, C; Sinagra, G; Tavazzi, L; Tognoni, G | 1 |
| Cruickshank, JM | 1 |
| Inoko, M; Nohara, R | 1 |
| Bouzamondo, A; Hulot, JS; Lechat, P; Sanchez, P | 1 |
| Goldstein, S; Sallach, JA | 1 |
| Abou-Sekkina, MM; El-Ries, MA; Hassan, SS; Wassel, A | 1 |
| Abakumov, IuE; Batutina, AM; Kukes, VG; Mamaev, VI; Ostroumova, OD; Zykova, AA | 1 |
| Al-Nasser, F; Bolger, AP | 1 |
| Francis, GS; Militello, M; Tang, WH | 1 |
| Lechat, PP | 1 |
| Gattis, W; Patel, MR | 1 |
| Adams, KF; Bristow, MR; Feldman, AM; Goldstein, S | 1 |
| Berry, C; Corbett, W; Fleisher, LA; Poldermans, D | 1 |
| Eschenhagen, T; Rau, T; Wuttke, H | 1 |
| Coffey, CS; Curtis, JP; Foody, JM; Hebert, PR; Ko, DT; Krumholz, HM; Sedrakyan, A | 1 |
| Di Lenarda, A; Sabbadini, G; Sinagra, G | 1 |
| Bozhko, AA; Kanopskiĭ, SG; Staritskiĭ, AG | 1 |
| Jafri, SM | 1 |
| Rone, T; Sauls, JL | 1 |
| Murakami, T | 1 |
| Díez Manglano, J | 1 |
| Kowey, PR | 1 |
| Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
| Hashimoto, Y; Igarashi, N; Igawa, A; Inoue, H; Kato, B; Nonomura, M; Nozawa, T; Taguchi, M; Tahara, K | 1 |
| Altimir, S; Coll, R; Díez, C; González, B; Herreros, J; Lupón, J; Rey-Joly, C; Urrutia, A; Valle, V | 1 |
| Filipiak, KJ; Opolski, G | 1 |
| Champagne, J; Connolly, SJ; Dorian, P; Fain, E; Gent, M; Hohnloser, SH; Israel, CW; Roberts, R | 1 |
| Dupliakov, DV; Glukhova, VL; Golovina, GA; Vozhdaeva, ZI | 1 |
| Cai, Y; Jia, J; Li, S; Liu, G; Liu, Y; Pan, C; Ren, J; Yu, C | 1 |
| Barkhausen, J; Magedanz, A; Mohrs, OK; Schlosser, T; Schmermund, A; Voigtländer, T | 1 |
| Chizyński, K; Goch, JH; Maciejewski, M; Ptaszyński, P; Ruta, J | 1 |
| Kawano, S | 1 |
| Somlói, M; Toldy-Schedel, E; Tomcsányi, J; Wettstein, A | 1 |
| Abildstrøm, SZ; Andersen, SS; Folke, F; Fosbøl, E; Gislason, GH; Hansen, ML; Køber, L; Madsen, M; Rasmussen, S; Schramm, TK; Sørensen, R; Torp-Pedersen, C | 1 |
| Allen LaPointe, NM; Anstrom, KJ; Hernandez, AF; Kramer, JM; Stafford, JA; Zhou, Y | 1 |
| Sal'nikov, EV | 1 |
| Adams, KF | 1 |
| Giles, TD | 1 |
| Bachmakov, I; Endress, B; Fromm, MF; Glaeser, H; König, J; Mörl, F | 1 |
| Barratt, JD; Gilbert, AL; Killer, G; Peck, R; Pratt, N; Ramsay, E; Roughead, EE; Ryan, P | 1 |
| Coleman, CF; Elsik, M; Hayward, CS; Jabbour, A; Keogh, AM; Kotlyar, E; Krum, H; Macdonald, PS; Mellemkjaer, S | 1 |
| Remme, WJ | 1 |
| Dronova, EP; Lopatin, IuM | 1 |
| Back, TG; Chen, H; Chen, J; Chen, SR; Chen, W; Cheng, H; Duff, HJ; Feldman, AM; Fill, M; Gillis, AM; Guo, A; Jiang, D; Jones, PP; Li, X; Smith, CD; Song, LS; Tian, X; Vembaiyan, K; Wang, A; Wang, R; Xiao, J; Xie, C; Yang, D; Zhang, J; Zhang, L; Zhong, X; Zhou, Q; Zhu, W | 1 |
| Kow, FP; Ong, HT | 1 |
| Cheng, XJ; He, YM; Li, X; Qian, YX; Xu, HF; Yang, XJ; Zhao, X | 1 |
| Colombo, P; Garan, AR; Hirsh, BJ; Jorde, UP; Mignatti, A; Sims, DB; Uriel, N | 1 |
| Guzik, P; Gwizdala, A; Katarzynska-Szymanska, A; Krauze, T; Mitkowski, P; Ochotny, R; Oko-Sarnowska, Z; Piskorski, J; Wachowiak-Baszynska, H | 1 |
| DiNicolantonio, JJ; Fares, H; Lavie, CJ; Menezes, AR; O'Keefe, JH | 1 |
| Díez-Manglano, J | 1 |
| Ashes, C; Beattie, WS; Hare, GM; Judelman, S; Mazer, CD; Tait, G; Wijeysundera, DN | 1 |
| Eisenach, JC | 1 |
| Castagno, D; McMurray, JJ; Wedel, H; Wikstrand, J | 1 |
| Furuichi, Y; Sakamoto, A | 1 |
| Gähwiler, R; Ghadri, JR; Lüscher, TF; Templin, C | 1 |
| Bronheim, D; Wicker, JF | 1 |
| Ashes, C; Beattie, WS; Hare, GM; Judelman, S; Mazer, CD; Tait, G; Wijeysundera, D | 1 |
| Chernikov, MV; Derevianchenko, MV; Lopushkova, IuE; Statsenko, ME | 1 |
| Cho, MJ; Jung Kwak, M; Kim, HY; Kim, YM; Lee, HD; Lim, RK; Park, KH | 1 |
| Jansson, SO; Lundström, T; Malm, AE | 1 |
| Emel'ianova, OI; Erokhina, IL; Okovityĭ, SV; Voronchikhin, PA | 1 |
| Giebułtowicz, J; Nałęcz-Jawecki, G; Sikorska, K; Stankiewicz, A; Stefański, M; Wroczyński, P | 1 |
| Andjelkovic, N; Davidovic, G; Djurdjevic, P; Ignjatovic, V; Ignjatovic, VD; Iric-Cupic, V; Jovanovic, D; Miloradovic, V; Nesic, J; Pavlovic, S; Petrovic, N; Simic, I; Simovic, S; Smiljanic, Z; Stolic, R; Zdravkovic, V | 1 |
| Hviid, A; Mattsson, A; Pasternak, B; Svanström, H | 1 |
| Falter, T; Haen, E; Hefner, G; Hiemke, C; Shams, ME; Unterecker, S; Wolf, M | 1 |
| Bocchi, EA; Böhm, M; Borer, JS; Ford, I; Komajda, M; Swedberg, K; Tavazzi, L | 1 |
| Ahn, Y; Jeong, MH; Jin, HY; Kim, DI; Kim, DK; Kim, KH; Seo, GW; Seol, SH; Song, PS; Yang, TH | 1 |
| Buś-Kwaśnik, K; Giebułtowicz, J; Kojro, G; Leś, A; Marszałek, R; Rudzki, PJ; Wroczyński, P | 1 |
| van Klei, WA | 1 |
| Chen, TH; Hong, CY; Sue, YM; Tang, CH; Wang, CC | 1 |
| Chang, YS; Chen, TJ; Chou, KT; Hu, YW; Hung, MH; Lee, FY; Liu, CJ; Ou, SM; Perng, DW; Su, VY; Yang, KY | 1 |
| Agharazii, M; Dupuis, D; Goupil, R; Madore, F; Troyanov, S | 1 |
| Fi, Z; Szentes, V | 1 |
| Hao, Y; Jiang, Y; Lin, X; Ma, T; Qu, B; Xu, X; Yang, T; Zhou, S | 1 |
| Bouvier, M; de Denus, S; Deblois, D; Dorais, M; Dubé, MP; Haibe-Kains, B; Jenna, S; Leduc, R; Perreault, S; Rouleau, JL; Tardif, JC; White, M; White-Guay, B | 1 |
| Chen, CY; Huang, YB; Lin, TY | 1 |
| Chen, RJ; Chu, H; Tsai, LW | 1 |
| Komal, C; Prachi, S; Priti, MJ | 1 |
| Agewall, S; Atar, D; Clark, AL; Cleland, JGF; Corletto, A; Frankenstein, L; Fröhlich, H; Goode, K; Grundtvig, M; Hole, T; Katus, HA; Kazmi, S; Schellberg, D; Täger, T; Torres, L | 1 |
| Fujito, K; Kimura, K; Takayanagi, R; Yamada, Y | 1 |
| Chen, CY; Huang, YB; Kuo, CC; Liao, KM; Lin, TY | 1 |
| Fuhr, U; Holzgrabe, U; Kinzig, M; Schroeter, M; Sigaroudi, A; Sörgel, F; Stelzer, C; Wahl, O | 1 |
| Andersen, MP; Capuano, A; Enghusen-Poulsen, H; Gislason, G; Mascolo, A; Mortensen, RN; Rosano, GMC; Rossi, F; Sessa, M; Torp-Pedersen, C | 1 |
| Ingram, A; Valente, M | 1 |
| Addison, D; Alam, M; Jneid, H; Kayani, W; Lakkis, N; Misra, A; Pham, D; Resar, J | 1 |
| Brown, TM; Chen, L; Durant, RW; Kilgore, ML; Levitan, EB; Loop, MS; Safford, MM; van Dyke, MK | 1 |
| Aldosary, AH; Almeman, AA; Beshir, YA | 1 |
| Baek, SH; Chae, SC; Cho, HJ; Cho, MC; Choi, DJ; Jeon, ES; Kang, SM; Kim, JJ; Kim, KH; Lee, HY; Oh, BH; Park, HA; Park, JJ; Yoo, BS | 1 |
| Andersen, M; Capuano, A; Jensen, MT; Kragholm, K; Mascolo, A; Pagliaro, C; Rafaniello, C; Rasmussen, DB; Rossi, F; Sessa, M; Sportiello, L; Tari, GM | 1 |
| Bedak, O; Begic, E; Bradaric, H; Custovic, F; Durak-Nalbantic, A; Hodzic, E; Mujakovic, A; Prnjavorac, B; Zvizdic, F | 1 |
| Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; El Rouby, N; Fyhrquist, F; Garofalidou, T; Glorioso, N; Glorioso, V; Gong, Y; Hiltunen, TP; Johnson, JA; Kontula, KK; McDonough, CW; Munroe, PB; Pepine, CJ; Salvi, E; Singh, S; Turner, ST; Wang, Z; Warren, HR; Zaninello, R | 1 |
| Beck, E; Hoeltzenbein, M; Kayser, A; Meister, R; Schaefer, C; Weber-Schoendorfer, C; Zinke, S | 1 |
| Andrews, LM; Koch, BCP; van der Nagel, BCH; van Domburg, B | 1 |
| Furukawa, K; Kasaoka, S; Matsubara, R; Satonaka, S; Tanaka, Y | 1 |
| Ansorge, M; Dovhunová, M; Galić, N; Habinovec, I; Pocrnić, M; Tesařová, E | 1 |
| Jacobsen, SJ; Kalantar-Zadeh, K; Kovesdy, CP; Lee, MS; Neyer, JR; Shaw, SF; Shi, J; Sim, JJ; Zhou, H | 1 |
| Aiglova, R; Danek, J; Gloger, V; Lazarova, M; Pavlu, L; Precek, J; Schee, A; Skala, T; Taborsky, M; Vicha, M | 1 |
| Ahl Hulme, R; Bass, GA; Cao, Y; Ekestubbe, L; Forssten, MP; Matthiessen, P; Mohseni, S; Sjölin, G | 1 |
| Ballotari, M; Gottardo, R; Tagliaro, F; Taus, F; Utzeri, C | 1 |
| Gedde-Dahl, A; Molden, E; Spigset, O | 1 |
| Blecker, SB; Dunlay, SM; Killian, JM; Redfield, MM; Roger, VL; Savitz, ST; Schulte, PJ | 1 |
| Bessa-Jambrina, S; Galán-Rodríguez, C; López-García, R; Marlés-Torres, A | 1 |
| Tchernev, G | 1 |
| Frey, N; Gampp, H; Hackbarth, J; Lugenbiel, P; Müller, ME; Petersenn, F; Pfeiffer, J; Rahm, AK; Rivinius, R; Thomas, D | 1 |
46 review(s) available for bisoprolol and metoprolol
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Adrenergic betablockers and heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Cardiomyopathy, Dilated; Heart Failure; Humans; Metoprolol; Survival Analysis; Sympathetic Nervous System; Treatment Outcome | 1995 |
[Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Controlled Clinical Trials as Topic; Follow-Up Studies; Heart Failure; Humans; Metoprolol; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Time Factors; Vasodilator Agents | 1998 |
Beta-blocker therapy in heart failure: pathophysiology and clinical results.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Exercise; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Quality of Life; Stroke Volume; Time Factors; Vasodilator Agents; Xamoterol | 1999 |
[Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Hemodynamics; Humans; Meta-Analysis as Topic; Metoprolol; Placebos; Propanolamines; Randomized Controlled Trials as Topic; Risk Factors; Time Factors | 1999 |
Major beta blocker mortality trials in chronic heart failure: a critical review.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Female; Heart Failure; Humans; Male; Metoprolol; Morbidity; Multicenter Studies as Topic; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left | 1999 |
Beta-adrenoceptor blockers in heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines; Treatment Outcome | 1999 |
beta-adrenergic receptor blockade in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Heart Function Tests; Humans; Metoprolol; Propanolamines; Receptors, Adrenergic, beta; Signal Transduction | 2000 |
The effect of beta-blockers on health-related quality of life in patients with heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Health Status; Heart Failure; Humans; Metoprolol; Propanolamines; Quality of Life | 2000 |
The impact of beta-blockade on mortality rates in patients with congestive heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Meta-Analysis as Topic; Metoprolol; Patient Selection; Propanolamines; Randomized Controlled Trials as Topic; Risk Factors; Survival Analysis; Treatment Outcome | 2000 |
Beta blockade in patients with congestive heart failure. Why, who, and how.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Heart Failure; Humans; Metoprolol; Patient Selection; Propanolamines; Ventricular Dysfunction, Left | 2000 |
Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure.
Topics: Adrenergic beta-Antagonists; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Heart Failure; Humans; Metoprolol; Nebivolol; Propanolamines | 2000 |
Beta blockers and congestive heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Meta-Analysis as Topic; Metoprolol; Propanolamines; Randomized Controlled Trials as Topic; Risk; Severity of Illness Index; Stroke Volume; Systole; Treatment Outcome | 2000 |
The importance of beta blockers in the treatment of heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Metoprolol; Patient Selection; Propanolamines; Randomized Controlled Trials as Topic; Severity of Illness Index | 2000 |
Influence of beta-blockers on mortality in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Humans; Metoprolol; Morbidity; Propanolamines; Randomized Controlled Trials as Topic; Treatment Outcome | 2000 |
Economic impact of beta blockade in heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Costs; Heart Failure; Humans; Metoprolol; Models, Economic; Propanolamines; Sensitivity and Specificity; United States | 2001 |
Beta-blockers to reduce mortality in patients with systolic dysfunction: a meta-analysis.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Hemodynamics; Humans; Metoprolol; Propanolamines; Research Design; Risk Factors; Severity of Illness Index; Systole; Treatment Outcome | 2001 |
[Adrenergic beta inhibitors in heart insufficiency: which and when?].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Patient Selection; Propanolamines; Randomized Controlled Trials as Topic; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2001 |
Antiarrhythmic properties of beta-blockers.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Bisoprolol; Humans; Metoprolol; Myocardial Infarction; Tachycardia, Supraventricular; Ventricular Fibrillation | 1990 |
[Role of beta-blockers in the treatment of chronic heart heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Controlled Clinical Trials as Topic; Disease Progression; Drug Administration Schedule; Heart Failure; Humans; Metoprolol; Myocardial Contraction; Patient Selection; Propanolamines; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
Beta-blockers in heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines | 2001 |
Beta-blockers and diabetes: the bad guys come good.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Bisoprolol; Coronary Disease; Diabetes Mellitus, Type 2; Humans; Hypertension; Metoprolol; Myocardial Infarction; Prognosis; Propranolol | 2002 |
[Use of beta-blockers in heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Contraindications; Heart Failure; Humans; Metoprolol; Propanolamines | 2003 |
Beta-blocker benefit according to severity of heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Hospitalization; Humans; Metoprolol; Propanolamines; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke Volume; Survival Analysis; Treatment Outcome | 2003 |
Use of beta-blockers in congestive heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Forecasting; Heart Failure; Humans; Metoprolol; Propanolamines; Randomized Controlled Trials as Topic | 2003 |
Beta-blockers for chronic heart failure: surviving longer but feeling better?
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Exercise Test; Exercise Tolerance; Heart Failure; Humans; Metoprolol; Propanolamines; Quality of Life | 2003 |
Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Europe; Heart Failure; Humans; Metoprolol; Propanolamines; Receptors, Adrenergic, beta-1; Risk Factors; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2003 |
[Genetic polymorphisms in drug metabolizing enzymes--impact on treatment with beta-blockers].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alleles; Atenolol; Benzopyrans; Biotransformation; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Cytochrome P-450 CYP2D6; Ethanolamines; Female; Genotype; Humans; Male; Metoprolol; Mutation; Nebivolol; Pharmacogenetics; Phenotype; Polymorphism, Genetic; Propanolamines; Risk Factors; Time Factors | 2004 |
The effects of beta blockers on morbidity and mortality in heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Morbidity; Multicenter Studies as Topic; Propanolamines; Randomized Controlled Trials as Topic; Survival Analysis; United States | 2004 |
Emerging trends in the management of heart failure: Beta blocker therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Cost of Illness; Diuretics; Drug Costs; Drug Therapy, Combination; Heart Failure; Humans; Metoprolol; Morbidity; Natriuretic Peptides; Nurse's Role; Patient Selection; Practice Guidelines as Topic; Propanolamines; Quality of Life; Renin-Angiotensin System; Severity of Illness Index; Sympathetic Nervous System; Treatment Outcome | 2005 |
[Beta blockers for therapy of chronic heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Clinical Trials as Topic; Heart Failure; Humans; Metoprolol; Propanolamines | 2005 |
[Congestive heart failure in Spain: cost-effectiveness and cost-benefit analyses of treatment with beta-blockers].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Cost-Benefit Analysis; Heart Failure; Humans; Metoprolol; Propanolamines; Randomized Controlled Trials as Topic; Spain | 2005 |
A review of carvedilol arrhythmia data in clinical trials.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Carbazoles; Carvedilol; Death, Sudden, Cardiac; Digoxin; Heart Failure; Humans; Metoprolol; Myocardial Infarction; Propanolamines; Randomized Controlled Trials as Topic | 2005 |
[Beta-adrenolytics in heart failure--are they all really equal?].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines | 2005 |
[Beta blockers: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Contraindications; Heart Failure; Humans; Metoprolol; Propanolamines | 2007 |
Beta-blockers in heart failure: how far have we progressed?
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Heart Failure; Humans; Metoprolol; Propanolamines; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2002 |
Use of beta-blockers for heart failure in patients with diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Diabetes Complications; Diabetes Mellitus; Heart Failure; Humans; Metoprolol; Propanolamines; United States | 2002 |
β-Blockers in heart failure: benefits of β-blockers according to varying male proportions of study patients.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; China; Heart Failure; Hospitalization; Humans; Male; Metoprolol; Propanolamines; Statistics as Topic; Vasodilator Agents | 2012 |
Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol).
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Global Health; Humans; Metoprolol; Myocardial Infarction; Nebivolol; Platelet Aggregation Inhibitors; Propanolamines; Survival Rate; Treatment Outcome | 2013 |
[Perioperative cardiovascular evaluation and management for noncardiac surgery].
Topics: Adrenergic beta-Antagonists; Anesthesia; Atenolol; Bisoprolol; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Intraoperative Complications; Metoprolol; Monitoring, Intraoperative; Morpholines; Myocardial Infarction; Myocardial Ischemia; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Urea | 2014 |
Effects of beta-blockers for congestive heart failure in pediatric and congenital heart disease patients: a meta-analysis of published studies.
Topics: Adrenergic beta-Antagonists; Age Factors; Bisoprolol; Carbazoles; Carvedilol; Child; Heart Defects, Congenital; Heart Failure; Humans; Metoprolol; Propanolamines; Ventricular Dysfunction, Left | 2015 |
[The benefits of carvedilol therapy in the treatment of patients with high cardiovascular risk].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Bisoprolol; Carbazoles; Cardiovascular Diseases; Carvedilol; Clinical Trials as Topic; Drug Prescriptions; Evidence-Based Medicine; Heart Failure; Hemodynamics; Humans; Hungary; Hypertension; Metoprolol; Multicenter Studies as Topic; Oxidative Stress; Primary Health Care; Propanolamines; Risk | 2016 |
Genetic Variation of Hepatic Enzymes Influence on β-Blocker Dose in Patients With Reduced Ejection Fraction Heart Failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carvedilol; Cytochrome P-450 CYP2D6; Genetic Variation; Heart Failure; Humans; Metoprolol; Research Design; Treatment Outcome | 2020 |
Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Carvedilol; Cocaine; Humans; Metoprolol; Propanolamines; Propranolol | 2018 |
Genome-Wide Meta-Analysis of Blood Pressure Response to β
Topics: ADP-ribosyl Cyclase; Adrenergic beta-1 Receptor Antagonists; Antigens, CD; Atenolol; Bisoprolol; Black People; Blood Pressure; Genome-Wide Association Study; GPI-Linked Proteins; Humans; Hypertension; Metoprolol; Mutation, Missense; Pharmacogenetics; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Treatment Outcome; White People | 2019 |
24 trial(s) available for bisoprolol and metoprolol
| Article | Year |
|---|---|
[Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol].
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Double-Blind Method; Female; Humans; Male; Metoprolol; Migraine Disorders; Propanolamines | 1992 |
[Preoperative treatment with beta-receptor blockers and isoflurane anesthesia. Hemodynamic interactions in patients with coronary disease].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anesthesia, Inhalation; Atenolol; Bisoprolol; Coronary Disease; Drug Interactions; Hemodynamics; Humans; Isoflurane; Metoprolol; Middle Aged; Preanesthetic Medication; Propanolamines | 1990 |
Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Bisoprolol; Dose-Response Relationship, Drug; Heart Rate; Humans; Male; Metoprolol; Physical Exertion; Propanolamines; Propranolol; Time Factors | 1986 |
Exercise blood pressure and heart rate reduction 24 and 3 hours after drug intake in hypertensive patients following 4 weeks of treatment with bisoprolol and metoprolol: a randomized multicentre double-blind study (BISOMET).
Topics: Adolescent; Adult; Aged; Bisoprolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Propanolamines; Random Allocation; Rest; Time Factors | 1987 |
Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Bronchi; Dose-Response Relationship, Drug; Heart Rate; Humans; Metoprolol; Physical Exertion; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 1984 |
Ventilatory effects of beta 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Bisoprolol; Blood Pressure; Forced Expiratory Volume; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Peak Expiratory Flow Rate; Propanolamines; Respiratory Function Tests; Vital Capacity | 1984 |
Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
Topics: Absorption; Administration, Oral; Adrenergic beta-Antagonists; Adult; Biological Availability; Bisoprolol; Cross-Over Studies; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Female; Humans; Male; Metoprolol; Reference Values; Tablets | 1996 |
[Do cardioselective beta-antagonists block the cardiac beta-receptor function also in the long run?].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bisoprolol; Cardiotonic Agents; Hemodynamics; Humans; Isoproterenol; Male; Metoprolol; Middle Aged; Receptors, Adrenergic, beta; Time Factors | 1998 |
Beta-blocker decreases the increase in QT dispersion and transmural dispersion of repolarization induced by bepridil.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Bisoprolol; Drug Antagonism; Drug Therapy, Combination; Electrocardiography; Female; Heart Conduction System; Humans; Long QT Syndrome; Male; Metoprolol; Middle Aged; Treatment Outcome | 2002 |
Beta-blocker benefit according to severity of heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Hospitalization; Humans; Metoprolol; Propanolamines; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke Volume; Survival Analysis; Treatment Outcome | 2003 |
[Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hypertension; Lung Diseases, Obstructive; Male; Metoprolol; Middle Aged; Treatment Outcome | 2003 |
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Dizziness; Fatigue; Female; Follow-Up Studies; Heart Conduction System; Heart Failure; Humans; Hypotension; Male; Metoprolol; Middle Aged; Propanolamines; Risk Factors; Risk Reduction Behavior; Severity of Illness Index; Statistics as Topic; Treatment Failure; Ventricular Dysfunction, Left; Withholding Treatment | 2004 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Carbazoles; Carvedilol; Combined Modality Therapy; Defibrillators, Implantable; Female; Heart Arrest; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Propanolamines; Sotalol; Ventricular Fibrillation; Ventricular Function, Left | 2006 |
[Cardioselective beta-adrenoblockers in patients with stable angina pectoris. Comparison of efficacy and safety].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzopyrans; Betaxolol; Bisoprolol; Blood Flow Velocity; Echocardiography; Ethanolamines; Exercise Tolerance; Female; Follow-Up Studies; Humans; Male; Metoprolol; Middle Aged; Myocardial Contraction; Nebivolol; Treatment Outcome | 2006 |
[Effect of low doses of metoprolol, bisoprolol and carvedilol on mortality in patients with left ventricular dysfunction after acute myocardial infarction].
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aged; Angioplasty, Balloon, Coronary; Bisoprolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Propanolamines; Retrospective Studies; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Switching beta-blocker therapy in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Chronic Disease; Heart Failure; Humans; Metoprolol | 2008 |
Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Cross-Over Studies; Echocardiography; Female; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Pulmonary Disease, Chronic Obstructive; Pulse; Respiratory Function Tests; Walking | 2010 |
[Clinical-pharmacoeconomical aspects of ß-adrenoblockers use in patients with ischemic heart disease undergoing coronary artery bypass grafting].
Topics: Adrenergic beta-1 Receptor Antagonists; Angina Pectoris; Atenolol; Bisoprolol; Comparative Effectiveness Research; Coronary Angiography; Coronary Artery Bypass; Cost Savings; Exercise Test; Female; Graft Occlusion, Vascular; Humans; Male; Metoprolol; Middle Aged; Patient Readmission; Time; Treatment Outcome | 2010 |
Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Biomarkers; Bisoprolol; Carbazoles; Carvedilol; Drug Administration Schedule; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Male; Metoprolol; Middle Aged; New York City; Norepinephrine; Oxygen Consumption; Propanolamines; Prospective Studies; Respiration; Time Factors | 2012 |
[Efficacy and safety of bisoprololal in hypertensive patients with cardiovascular disease and chronic obstructive pulmonary disease].
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Antihypertensive Agents; Bisoprolol; Cardiovascular Diseases; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2014 |
Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.
Topics: Adrenergic beta-Antagonists; Aged; Benzazepines; Bisoprolol; Carbazoles; Cardiovascular Agents; Carvedilol; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure, Systolic; Hospitalization; Humans; Ivabradine; Male; Metoprolol; Middle Aged; Nebivolol; Propanolamines; Proportional Hazards Models; Treatment Outcome | 2015 |
Impact of Carvedilol versus β1-selective β blockers (bisoprolol, metoprolol, and nebivolol) in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Carbazoles; Carvedilol; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Nebivolol; Percutaneous Coronary Intervention; Preoperative Care; Propanolamines; Prospective Studies; Registries; Republic of Korea; Retrospective Studies; Survival Rate; Treatment Outcome | 2015 |
Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study.
Topics: Adult; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Treatment Outcome | 2017 |
Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Bisoprolol; Carvedilol; Cause of Death; Comorbidity; Denmark; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Male; Metoprolol; Nebivolol; Pulmonary Disease, Chronic Obstructive; Registries; Retrospective Studies; Time Factors; Treatment Outcome | 2018 |
104 other study(ies) available for bisoprolol and metoprolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
High-throughput log P determination by ultraperformance liquid chromatography: a convenient tool for medicinal chemists.
Topics: Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Chromatography, Liquid; Mathematics; Pharmaceutical Preparations; Software | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Uncoupling the Structure-Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding.
Topics: Binding Sites; Cell Membrane; Dose-Response Relationship, Drug; Humans; Ligands; Models, Molecular; Molecular Structure; Receptors, Adrenergic, beta-2; Structure-Activity Relationship | 2016 |
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Propanols; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Cardiovascular effect of low-dose epinephrine infusions in relation to the extent of preoperative beta-adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Epinephrine; Hemodynamics; Humans; Metoprolol; Middle Aged; Myocardial Revascularization; Pindolol; Preoperative Care; Propanolamines | 1991 |
Differential regulation of human cardiac beta-adrenergic and muscarinic receptors by chronic beta-adrenoceptor antagonist treatment.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bisoprolol; Electric Stimulation; Humans; In Vitro Techniques; Iodocyanopindolol; Metoprolol; Middle Aged; Myocardial Contraction; Myocardium; N-Methylscopolamine; Parasympatholytics; Pindolol; Propanolamines; Receptors, Adrenergic, beta; Receptors, Muscarinic; Scopolamine Derivatives | 1990 |
Respiratory tolerance of bisoprolol and metoprolol in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Asthma; Bisoprolol; Bronchial Spasm; Humans; Male; Metoprolol; Peak Expiratory Flow Rate; Propanolamines; Respiration; Vital Capacity | 1986 |
Effects of bisoprolol in relation to metoprolol and bufuralol on left ventricular hemodynamics at rest and during exercise in chronic ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Coronary Circulation; Coronary Disease; Ethanolamines; Heart; Heart Ventricles; Hemodynamics; Humans; Metoprolol; Middle Aged; Physical Exertion; Propanolamines; Rest; Time Factors | 1986 |
Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Kinetics; Metoprolol; Propanolamines; Propranolol | 1986 |
A sustained increase in beta-adrenoceptors during long-term therapy with metoprolol and bisoprolol in patients with heart failure from idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Cardiomyopathy, Dilated; Heart Function Tests; Humans; Iodine Radioisotopes; Metoprolol; Middle Aged; Radioligand Assay; Receptors, Adrenergic, beta-2; Stereoisomerism | 1996 |
Effects of beta-blockade on atrial and atrioventricular nodal refractoriness, and atrial fibrillatory rate during atrial fibrillation in pigs.
Topics: Adrenergic beta-Antagonists; Animals; Atrial Fibrillation; Atrioventricular Node; Bisoprolol; Catecholamines; Electrocardiography; Electrophysiology; Heart Atria; Male; Metoprolol; Refractory Period, Electrophysiological; Swine | 1997 |
Downregulation of beta-adrenergic receptors by low density lipoproteins and its prevention by beta-adrenergic receptor antagonists.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Bisoprolol; Cell Membrane; Coronary Vessels; Dose-Response Relationship, Drug; Down-Regulation; Female; In Vitro Techniques; Lipoproteins, LDL; Male; Metoprolol; Muscle, Smooth, Vascular; Propanolamines; Swine | 1998 |
Beta adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Bisoprolol; Coronary Disease; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Metoprolol; Middle Aged; Multivariate Analysis; Renin; Statistics, Nonparametric | 1998 |
Pharmacological treatment of systolic heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Heart Failure; Humans; Metoprolol; Research Design | 1999 |
[The role of beta-adrenergic blocking agents in treatment of heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines | 1999 |
[New milestones in the therapy of chronic heart failure with beta blockers].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Controlled Clinical Trials as Topic; Double-Blind Method; Heart Failure; Humans; Metoprolol; Placebos; Prognosis; Propanolamines; Quality of Life; Randomized Controlled Trials as Topic | 2000 |
Beta-blockers for heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Heart Failure; Humans; Hypotension; Metoprolol; Propanolamines | 2000 |
[Beta-blockers in the treatment of chronic heart failure. How should results of clinical studies be introduced into clinical practice].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines | 2000 |
Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells.
Topics: Adrenergic beta-Antagonists; Apoptosis; Becaplermin; Benzopyrans; Bisoprolol; Cell Culture Techniques; Cell Division; Cells, Cultured; Depression, Chemical; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Endothelium, Vascular; Ethanolamines; Gene Expression; Humans; In Situ Hybridization; Male; Metoprolol; Muscle, Smooth, Vascular; Nebivolol; Nitric Oxide; Platelet-Derived Growth Factor; Propranolol; Protein Precursors; Proto-Oncogene Proteins c-sis; RNA, Messenger; Transforming Growth Factor beta | 2001 |
Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Cardiomyopathy, Dilated; Cytokines; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Inflammation Mediators; Male; Metoprolol; Middle Aged; Treatment Outcome; Ventricular Function, Left | 2001 |
Anti beta1-adrenoceptor autoantibodies analyzed in spontaneously beating neonatal rat heart myocyte cultures-comparison of methods.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Autoantibodies; Biological Assay; Bisoprolol; Cardiomyopathy, Dilated; Chagas Disease; Electrophoresis, Polyacrylamide Gel; Heart Rate; Humans; Hypertension; Image Processing, Computer-Assisted; Immunosorbent Techniques; Metoprolol; Myocardium; Rats; Receptors, Adrenergic, beta-1 | 2001 |
Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
Topics: Adrenergic beta-Antagonists; Benzopyrans; Binding, Competitive; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Female; Guanylyl Imidodiphosphate; Heart Ventricles; Humans; Imidazoles; In Vitro Techniques; Inhibitory Concentration 50; Isoproterenol; Male; Metoprolol; Middle Aged; Myocardial Contraction; Myocardium; Nebivolol; Propanolamines; Substrate Specificity; Sympathetic Nervous System; Sympathomimetics; Thermodynamics | 2001 |
Unique effects of carvedilol on noradrenaline release in the human heart.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Heart; Heart Failure; Humans; Metoprolol; Myocardium; Norepinephrine; Propanolamines; Treatment Outcome | 2002 |
Current research on carvedilol in heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines | 2002 |
Beta-blockers work as well in women as in men.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Clinical Trials as Topic; Female; Heart Failure; Hospitalization; Humans; Male; Men; Metoprolol; Practice Guidelines as Topic; Risk Factors; Sex Factors; Treatment Outcome; United States; Women; Women's Health | 2002 |
Development, validation and analytical error function of two chromatographic methods with fluorimetric detection for the determination of bisoprolol and metoprolol in human plasma.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Chromatography, High Pressure Liquid; Humans; Metoprolol; Reference Standards; Spectrometry, Fluorescence | 2002 |
Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Cardiac Output, Low; Carvedilol; Chronic Disease; Contraindications; Female; Follow-Up Studies; Humans; Male; Metoprolol; Middle Aged; Multivariate Analysis; Professional Practice; Propanolamines; Treatment Outcome | 2003 |
Polymeric matrix membrane sensors for sensitive potentiometric determination of some beta-blockers in pharmaceutical preparations.
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Indicators and Reagents; Ions; Metoprolol; Phosphates; Polyvinyl Chloride; Potentiometry; Propranolol; Sensitivity and Specificity; Timolol; Tungsten Compounds | 2003 |
[For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Double-Blind Method; Follow-Up Studies; Heart Failure; Humans; Metoprolol; Multicenter Studies as Topic; Propanolamines; Randomized Controlled Trials as Topic; Time Factors | 2003 |
In heart failure, all beta-blockers are not necessarily equal.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Cost-Benefit Analysis; Female; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Propanolamines | 2003 |
Beta-blocker efficacy according to heart rate and rhythm in patients with heart failure. Commentary on the Cardiac Insufficiency Bisoprolol Study II analysis.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Heart Conduction System; Heart Failure; Heart Rate; Humans; Metoprolol; Randomized Controlled Trials as Topic; Treatment Outcome | 2003 |
Which beta-blocker for heart failure?
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Coronary Disease; Evidence-Based Medicine; Heart Failure; Humans; Hypertension; Male; Metoprolol; Middle Aged; Propanolamines; Randomized Controlled Trials as Topic | 2004 |
Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aortic Aneurysm, Abdominal; Atenolol; Bisoprolol; Cost-Benefit Analysis; Decision Support Techniques; Humans; Infusions, Intravenous; Metoprolol; Perioperative Care; Postoperative Complications; Propanolamines; Treatment Outcome; Vascular Surgical Procedures | 2004 |
Do pharmacological differences among beta-blockers affect their clinical efficacy in heart failure?
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2 | 2004 |
[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atenolol; Baroreflex; Bisoprolol; Carbazoles; Carvedilol; Data Interpretation, Statistical; Death, Sudden, Cardiac; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Perindopril; Phenylephrine; Propanolamines; Time Factors; Ventricular Dysfunction, Left | 2004 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
Influence of CYP2D6 genotype on metoprolol plasma concentration and beta-adrenergic inhibition during long-term treatment: a comparison with bisoprolol.
Topics: Adrenergic beta-Antagonists; Aged; Alleles; Bisoprolol; Blood Pressure; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Circadian Rhythm; Cytochrome P-450 CYP2D6; DNA; Drug Administration Schedule; Female; Genotype; Heart Rate; Humans; Male; Metabolic Clearance Rate; Metoprolol; Middle Aged; Polymerase Chain Reaction; Receptors, Adrenergic, beta; Time Factors | 2005 |
[Use of betablockers in elderly patients with congestive heart failure].
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Data Interpretation, Statistical; Female; Heart Failure; Humans; Male; Metoprolol; Propanolamines; Risk Factors; Survival Analysis; Time Factors; Treatment Outcome; Vasodilator Agents | 2006 |
Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography--tandem mass spectrometry.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, Liquid; Diltiazem; Humans; Metoprolol; Mexiletine; Molecular Structure; Propanolamines; Propranolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry; Verapamil | 2007 |
Assessment of left ventricular function and mass in patients undergoing computed tomography (CT) coronary angiography using 64-detector-row CT: comparison to magnetic resonance imaging.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Cardiac Output; Coronary Angiography; Female; Heart Rate; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Metoprolol; Middle Aged; Organ Size; Reference Standards; Retrospective Studies; Stroke Volume; Tomography, X-Ray Computed; Ventricular Dysfunction, Left | 2007 |
Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Bisoprolol; Female; Humans; Kaplan-Meier Estimate; Male; Metoprolol; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Recurrence; Registries; Sotalol | 2009 |
Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Comorbidity; Coronary Artery Disease; Female; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Survival Analysis; Ventricular Dysfunction, Left | 2009 |
Heart rate variability in rats with experimental chronic heart failure and long-term exposure to beta-adrenoblockers.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzopyrans; Bisoprolol; Ethanolamines; Heart Failure; Heart Rate; Male; Metoprolol; Nebivolol; Pindolol; Propranolol; Rats | 2009 |
Interaction of beta-blockers with the renal uptake transporter OCT2.
Topics: Adrenergic beta-Antagonists; Biological Transport; Bisoprolol; Carbazoles; Carvedilol; Cell Line; Humans; Kidney; Metformin; Metoprolol; Organic Cation Transport Proteins; Organic Cation Transporter 2; Propanolamines; Propranolol | 2009 |
The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Australia; Bisoprolol; Carbazoles; Carvedilol; Community Pharmacy Services; Cooperative Behavior; Databases as Topic; Family Practice; Female; Heart Failure; Hospitalization; House Calls; Humans; Kaplan-Meier Estimate; Male; Metoprolol; Program Evaluation; Propanolamines; Proportional Hazards Models; Referral and Consultation; Retrospective Studies; Risk Assessment; Time Factors; Treatment Outcome; Veterans; Widowhood | 2009 |
Which beta-blocker is most effective in heart failure?
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus; Disease Progression; Ethanolamines; Heart Failure; Humans; Lung Diseases, Obstructive; Metoprolol; Myocardial Infarction; Nebivolol; Propanolamines; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2010 |
Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bisoprolol; Calcium; Calcium Channel Blockers; Carbazoles; Carvedilol; Cell Line; Drug Therapy, Combination; Electrocardiography; Gene Knock-In Techniques; Humans; Metoprolol; Mice; Mice, Mutant Strains; Microscopy, Confocal; Mutation, Missense; Propanolamines; Ryanodine Receptor Calcium Release Channel | 2011 |
Beta-blockers for heart failure: why you should use them more.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Evidence-Based Medicine; Heart Failure, Systolic; Humans; Metoprolol; Practice Guidelines as Topic; Propanolamines; Treatment Outcome | 2011 |
Shortening baroreflex delay in hypertrophic cardiomyopathy patients -- an unknown effect of β-blockers.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Baroreflex; Bisoprolol; Cardiomyopathy, Hypertrophic; Case-Control Studies; Female; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Time Factors; Young Adult | 2013 |
[Economic analysis of the treatment of heart failure with beta-blockers].
Topics: Adrenergic beta-Antagonists; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Costs; Ethanolamines; Heart Failure; Hospitalization; Humans; Meta-Analysis as Topic; Metoprolol; Nebivolol; Propanolamines | 2013 |
Selective β1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Atenolol; Bisoprolol; Cohort Studies; Female; Humans; Male; Metoprolol; Ontario; Postoperative Complications; Retrospective Studies; Stroke | 2013 |
Patient safety: anesthesiology contributions and supplements to the American Society of Anesthesiologists' Annual Meeting.
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Bisoprolol; Female; Humans; Male; Metoprolol; Postoperative Complications; Stroke | 2013 |
The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Delayed-Action Preparations; Ethanolamines; Female; Heart Failure, Systolic; Hospitalization; Humans; Male; Metoprolol; Middle Aged; Nebivolol; Propanolamines; Randomized Controlled Trials as Topic; Risk; Severity of Illness Index; Stroke Volume; Treatment Outcome | 2014 |
[A heart without overspeed trip unit].
Topics: Adult; Algorithms; Benzazepines; Bisoprolol; Diagnosis, Differential; Drug Therapy, Combination; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Exercise Test; Firefighters; Humans; Ivabradine; Male; Metoprolol; Oxygen; Physical Examination; Physical Fitness; Signal Processing, Computer-Assisted; Tachycardia, Sinus; Ventricular Dysfunction, Left | 2014 |
Does β selectivity really affect outcome?
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Bisoprolol; Female; Humans; Male; Metoprolol; Postoperative Complications; Stroke | 2014 |
In reply.
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Bisoprolol; Female; Humans; Male; Metoprolol; Postoperative Complications; Stroke | 2014 |
In Silico comparison between metoprolol succinate and bisoprolol on 24-hour systolic blood pressures.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Computer Simulation; Delayed-Action Preparations; Humans; Metoprolol; Models, Biological | 2014 |
[Reaction of population of pulmonary mast cells in rat bronchial asthma under the effect of β-adrenoreceptor antagonists].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alcian Blue; Animals; Anti-Asthmatic Agents; Asthma; Bisoprolol; Budesonide; Cell Count; Disease Models, Animal; Drug Therapy, Combination; Glucocorticoids; Lung; Male; Mast Cells; Metoprolol; Phenazines; Rats; Receptors, Adrenergic, beta | 2013 |
The development of the LC-MS/MS method based on S-9 biotransformation for detection of metabolites of selected β-adrenolytics in surface water.
Topics: Adrenergic beta-Antagonists; Animals; Biotransformation; Bisoprolol; Chromatography, Liquid; Liver; Male; Metoprolol; Poland; Propranolol; Rats, Sprague-Dawley; Rivers; Tandem Mass Spectrometry; Waste Disposal, Fluid; Water Pollutants, Chemical | 2015 |
Influence of Different β-Blockers on Platelet Aggregation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aspirin; Bisoprolol; Carbazoles; Carvedilol; Clopidogrel; Coronary Artery Disease; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Metoprolol; Middle Aged; Nebivolol; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Propanolamines; Prospective Studies; Ticlopidine; Treatment Outcome | 2016 |
Comparative effectiveness of bisoprolol and metoprolol succinate in patients with heart failure.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Bisoprolol; Cohort Studies; Denmark; Female; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Registries; Treatment Outcome | 2015 |
Melperone but not bisoprolol or metoprolol is a clinically relevant inhibitor of CYP2D6: evidence from a therapeutic drug monitoring survey.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Bisoprolol; Butyrophenones; Cytochrome P-450 CYP2D6 Inhibitors; Databases, Pharmaceutical; Drug Monitoring; Female; Humans; Male; Metoprolol; Middle Aged; Retrospective Studies; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride; Young Adult | 2015 |
Cloud-point extraction is compatible with liquid chromatography coupled to electrospray ionization mass spectrometry for the determination of bisoprolol in human plasma.
Topics: Bisoprolol; Blood Chemical Analysis; Chromatography, Liquid; Humans; Liquid-Liquid Extraction; Metoprolol; Plasma; Spectrometry, Mass, Electrospray Ionization | 2015 |
[Which is the preferred perioperative beta-blocker?].
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Humans; Metoprolol; Perioperative Care; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Surgical Procedures, Operative | 2015 |
Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Chi-Square Distribution; Databases, Factual; Delayed-Action Preparations; Drug Compounding; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Metoprolol; Middle Aged; Multivariate Analysis; Propanolamines; Propensity Score; Proportional Hazards Models; Renal Dialysis; Retrospective Studies; Risk Factors; Taiwan; Time Factors; Treatment Outcome | 2016 |
Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Female; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Taiwan; Young Adult | 2016 |
Heart rate dependent and independent effects of beta-blockers on central hemodynamic parameters: a propensity score analysis.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Atenolol; Bisoprolol; Blood Pressure; Cross-Sectional Studies; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Propensity Score; Pulse Wave Analysis | 2016 |
Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Cohort Studies; Databases, Factual; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Metoprolol; Propanolamines; Propensity Score; Proportional Hazards Models; Quebec; Treatment Outcome | 2017 |
Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Female; Heart Failure; Hospitalization; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Propensity Score; Proportional Hazards Models; Retrospective Studies; Taiwan; Treatment Outcome | 2017 |
Impact of Beta-Blocker Initiation Timing on Mortality Risk in Patients With Diabetes Mellitus Undergoing Noncardiac Surgery: A Nationwide Population-Based Cohort Study.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Female; Hospital Mortality; Humans; Male; Metoprolol; Middle Aged; Mortality; Odds Ratio; Perioperative Care; Propanolamines; Propensity Score; Protective Factors; Risk Factors; Surgical Procedures, Operative; Taiwan; Time Factors | 2017 |
Influence of Peroxide Impurities in Povidone on the Stability of Selected β-Blockers with the Help of HPLC.
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, High Pressure Liquid; Drug Contamination; Drug Stability; Excipients; Metoprolol; Oxidation-Reduction; Peroxides; Povidone; Propanolamines | 2017 |
Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; England; Female; Follow-Up Studies; Germany; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Norway; Propanolamines; Registries; Treatment Outcome | 2017 |
Analysis of Clinical Efficacy and Adverse Effects of β-Blocking Agents Used Clinically for Chronic Heart Failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Forced Expiratory Volume; Heart Failure; Heart Rate; Humans; Metoprolol; Models, Biological; Propanolamines; Treatment Outcome; Ventricular Function, Left | 2017 |
The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Chi-Square Distribution; Databases, Factual; Disease Progression; Female; Heart Failure; Hospitalization; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Propensity Score; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Taiwan; Time Factors; Treatment Outcome | 2017 |
Quantification of Bisoprolol and Metoprolol in Simultaneous Human Serum and Cerebrospinal Fluid Samples.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Bisoprolol; Humans; Metoprolol; Middle Aged | 2018 |
Low Utilization of Beta-Blockers Among Medicare Beneficiaries Hospitalized for Heart Failure With Reduced Ejection Fraction.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Bisoprolol; Carvedilol; Cohort Studies; Drug Prescriptions; Female; Heart Failure; Humans; Male; Medicare Part D; Medication Adherence; Metoprolol; Retrospective Studies; Stroke Volume; United States | 2019 |
Comparison of the Effects of Metoprolol and Bisoprolol on Lipid and Glucose Profiles in Cardiovascular Patients.
Topics: Antihypertensive Agents; Bisoprolol; Cardiovascular Diseases; Cross-Sectional Studies; Electrocardiography; Female; Glucose; Humans; Lipids; Male; Metoprolol; Middle Aged; Retrospective Studies; Treatment Outcome | 2019 |
β-Blockers and 1-Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carvedilol; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Metoprolol; Nebivolol; Patient Discharge; Prospective Studies; Republic of Korea; Stroke Volume; Survival Rate; Time Factors; Treatment Outcome | 2019 |
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrioventricular Block; Bisoprolol; Carvedilol; Cerebrovascular Disorders; Cohort Studies; Comorbidity; Drug Prescriptions; Drug Substitution; Drug Utilization; Female; Heart Failure; Hospitalization; Humans; Italy; Male; Metoprolol; Nebivolol; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Registries; Renal Insufficiency, Chronic; Retrospective Studies; Thrombosis | 2019 |
Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bisoprolol; Case-Control Studies; Digoxin; Disease Progression; Forced Expiratory Volume; Humans; Metoprolol; Nebivolol; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Verapamil; Vital Capacity | 2019 |
Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Birth Weight; Bisoprolol; Cohort Studies; Female; Humans; Hypertension; Infant; Infant, Newborn; Infant, Small for Gestational Age; Male; Metoprolol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Premature Birth; Prenatal Exposure Delayed Effects; Risk Factors | 2020 |
High-throughput quantification of ten antiarrhythmic drugs in human plasma using UPLC-MS/MS.
Topics: Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carvedilol; Chromatography, High Pressure Liquid; Diltiazem; Flecainide; High-Throughput Screening Assays; Humans; Lidocaine; Metoprolol; Propranolol; Reproducibility of Results; Sotalol; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Verapamil | 2019 |
The influence of viscosity-enhancing agents on oral absorption of drugs.
Topics: Administration, Oral; Animals; Area Under Curve; Bisoprolol; Diffusion; Excipients; Hypromellose Derivatives; Intestinal Absorption; Male; Metoprolol; Polyvinyl Alcohol; Rats; Rats, Wistar; Viscosity | 2019 |
Chiral separation of beta-blockers by high-performance liquid chromatography and determination of bisoprolol enantiomers in surface waters.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Chromatography, High Pressure Liquid; Labetalol; Metoprolol; Water | 2020 |
β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atenolol; Bisoprolol; Carvedilol; Cause of Death; Cohort Studies; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Mortality; Nadolol; Proportional Hazards Models; Propranolol; Protective Factors; Renal Dialysis; Retrospective Studies; Risk; Risk Factors | 2021 |
Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic.
Topics: Adrenergic beta-Antagonists; Betaxolol; Bisoprolol; Carbazoles; Carvedilol; Czech Republic; Heart Failure; Humans; Metoprolol; Nebivolol; Propanolamines; Retrospective Studies | 2021 |
Pharmacological differences between beta-blockers and postoperative mortality following colon cancer surgery.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Bisoprolol; Colonic Neoplasms; Humans; Metoprolol; Retrospective Studies | 2022 |
Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bisoprolol; Calcium; Calcium Channel Blockers; Chromatography, Liquid; Hair Analysis; Humans; Labetalol; Metoprolol; Nadolol; Nebivolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry | 2022 |
Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway.
Topics: Antidepressive Agents; Atenolol; Bisoprolol; Bupropion; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Drug Prescriptions; Fluoxetine; Humans; Metoprolol; Paroxetine; Retrospective Studies | 2022 |
Guideline-Directed Medical Therapy in Newly Diagnosed Heart Failure With Reduced Ejection Fraction in the Community.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carvedilol; Female; Heart Failure; Humans; Male; Metoprolol; Mineralocorticoid Receptor Antagonists; Neprilysin; Receptors, Angiotensin; Retrospective Studies; Stroke Volume; Treatment Outcome | 2022 |
Ultra-high-speed liquid chromatography combined with mass spectrometry detection analytical methods for the determination of nitrosamine drug substance-related impurities.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Chromatography, High Pressure Liquid; Drug Contamination; Mass Spectrometry; Metoprolol | 2023 |
THE NITROSAMINE CONTAMINATION IN BETA BLOCKERS (BISOPROLOL/METOPROLOL), ACE INHIBITORS (LISINOPRIL/PERINDOPRIL), THIAZIDES DIURETICS (HCT), CALCIUM CHANNEL BLOCKERS (AMLODIPINE/FELODIPINE), SARTANS (CANDESARTAN) AND ТHE SUBSEQUENT SKIN CANCER DEVELOPMENT
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Felodipine; Humans; Lisinopril; Melanoma; Metoprolol; Nitrosamines; Perindopril; Prospective Studies; Skin Neoplasms; Sodium Chloride Symporter Inhibitors; Thiazides | 2023 |
Differential Effects of the Betablockers Carvedilol, Metoprolol and Bisoprolol on Cardiac K
Topics: Bisoprolol; Carvedilol; Heart; Heart Failure; Humans; Metoprolol; Protein Isoforms | 2023 |